|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents (includes pledged assets of $2,546,553 and $1,683,059, respectively) | ||||||||||||||||||||
| Securities (includes pledged assets of $83,286,913 and $82,809,634, respectively) | ||||||||||||||||||||
| Loans, net (includes pledged assets of $6,885,511 and $4,590,517, respectively) | ||||||||||||||||||||
| Mortgage servicing rights (includes pledged assets of $3,472,452 and $3,541,414, respectively) | ||||||||||||||||||||
| Interests in MSR | ||||||||||||||||||||
| Assets transferred or pledged to securitization vehicles | ||||||||||||||||||||
| Derivative assets | ||||||||||||||||||||
| Reverse repurchase agreements | ||||||||||||||||||||
| Receivable for unsettled trades | ||||||||||||||||||||
| Principal and interest receivable | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders’ equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Repurchase agreements | ||||||||||||||||||||
| Other secured financing | ||||||||||||||||||||
| Debt issued by securitization vehicles | ||||||||||||||||||||
| Participations issued | ||||||||||||||||||||
| U.S. Treasury securities sold, not yet purchased | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Payable for unsettled trades | ||||||||||||||||||||
| Interest payable | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Preferred stock, par value $0.01 per share, 75,000,000 authorized, 74,500,000 issued and outstanding | ||||||||||||||||||||
| Preferred stock outstanding (shares) | ||||||||||||||||||||
| Common stock, par value $0.01 per share, 1,456,750,000 authorized, 750,574,308 and 706,972,452 issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
| Common Stock, shares authorized (in shares) | ||||||||||||||||||||
| Common stock, par value (USD per share) | ||||||||||||||||||||
Loading...
